Cited by 309Cancer-related Molecular PathwaysDevelopmental Biology and Gene RegulationCell death mechanisms and regulation

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

The p53 family in differentiation and tumorigenesis

Stiewe, Thorsten·2007·Nature Reviews Cancer

DOI 10.1038/nrc2072

Open this paper in CoChat — free account

Abstract

The role of p53 as a tumour suppressor is generally attributed to its ability to stop the proliferation of precancerous cells by inducing cell-cycle arrest or apoptosis. The relatives and evolutionary predecessors of p53 - p63 and p73 - share the tumour-suppressor activity of p53 to some extent, but also have essential functions in embryonic development and differentiation control. Recent evidence indicates that these ancestral functions in differentiation control contribute to the tumour-suppressor activity that the p53 family is famous for.

Integrity signals

Registry

Crossref · 10.1038/nrc2072

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Surfing the p53 network
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“jpg" NDATA ITEM> ]> The tumour suppressor p53 is known as the 'guardian of the genome' owing to its ability to integrate many signals that control life or deat”
Background
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C. J., Sharpe, A. H., Caput, D., Crum, C. P., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,264
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
p63 is a p53 homologue required for limb and epidermal morphogenesis
Mills, A. A., Zheng, B., Wang, X., Vogel, H. S., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 2,015
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours
Yang, A., Walker, N., Bronson, R. T., Kaghad, M., Oosterwegel, M. A., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A. H., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 1,022
p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression
Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., & Xu, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1211 · Cited by 859
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
Flores, E. R., Tsai, K. Y., Crowley, D. G., Sengupta, S., Yang, A., McKeon, F., & Jacks, T. (2002) · Nature · doi:10.1038/416560a · Cited by 815
p53 isoforms can regulate p53 transcriptional activity
Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P. (2005) · Genes & Development · doi:10.1101/gad.1339905 · Cited by 810

Show all 38 references

Sorted by citations

The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705
p53 polymorphisms: cancer implications
Whibley, C., Pharoah, P. D. P., & Hollstein, M. C. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2584 · Cited by 677
Biological response of cancer cells to radiation treatment
Baskar, R., Dai, J., Nei, W. L., Yeo, R., & Yeoh, K. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00024 · Cited by 696
Strategies for optimizing the response of cancer and normal tissues to radiation
Moding, E. J., Kastan, M. B., & Kirsch, D. G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4003 · Cited by 474
Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
Zhao, Y., Aguilar, A., Bernard, D., & Wang, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501092z · Cited by 462
TAp73 knockout shows genomic instability with infertility and tumor suppressor functionsPreprint
Tomasini, R., Tsuchihara, K., Wilhelm, M., Fujitani, M., Rufini, A., Cheung, C. C., Khan, F., Itie-YouTen, A., Wakeham, A. C., Tsao, M., et al. (2008) · Genes & Development · doi:10.1101/gad.1695308 · Cited by 440
The role of mutant p53 in human cancer
Goh, A. M., Coffill, C. R., & Lane, D. P. (2010) · The Journal of Pathology · doi:10.1002/path.2784 · Cited by 408
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm
Soussi, T., & Wiman, K. G. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.001 · Cited by 375
GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability
Hu, W. L., Jin, L., Xu, A., Wang, Y. F., Thorne, R. F., Zhang, X. D., & Wu, M. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0066-7 · Cited by 346
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression
Li, Y., Yang, J., Aguilar, A., McEachern, D., Przybranowski, S., Liu, L., Yang, C.-Y., Wang, M., Han, X., & Wang, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00909 · Cited by 312
Targeting the MDM2–p53 Protein–Protein Interaction for New Cancer Therapy: Progress and Challenges
Wang, S., Zhao, Y., Aguilar, A., Bernard, D., & Yang, C.-Y. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026245 · Cited by 300
Trim24 targets endogenous p53 for degradation
Allton, K., Jain, A. K., Herz, H.-M., Tsai, W.-W., Jung, S. Y., Qin, J., Bergmann, A., Johnson, R. L., & Barton, M. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813177106 · Cited by 292
Nucleolar stress with and without p53
James, A., Wang, Y., Raje, H. S., Rosby, R., & DiMario, P. J. (2014) · Nucleus · doi:10.4161/nucl.32235 · Cited by 280
The p53 family: guardians of maternal reproduction
Levine, A. J., Tomasini, R., McKeon, F., Mak, T. W., & Melino, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3086 · Cited by 260
Cellular signaling perturbation by natural products
Sarkar, F. H., Li, Y., Wang, Z. P., & Kong, D. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.03.009 · Cited by 246
p53 and its isoforms in cancer
Bourdon, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603886 · Cited by 254
Molecular mechanisms of cervical carcinogenesis by high‐risk human papillomaviruses: novel functions of E6 and E7 oncoproteins
Yugawa, T., & Kiyono, T. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.605 · Cited by 236
DNA Mismatch Repair Gene Polymorphisms Affect Survival in Pancreatic Cancer
Dong, X., Li, Y., Hess, K. R., Abbruzzese, J. L., & Li, D. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0127 · Cited by 216
Flavonoids as Protein Kinase Inhibitors for Cancer Chemoprevention: Direct Binding and Molecular Modeling
Hou, D., & Kumamoto, T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2816 · Cited by 216
Revealing Global Regulatory Perturbations across Human Cancers
Goodarzi, H., Elemento, O., & Tavazoie, S. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.016 · Cited by 196
20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2731 · Cited by 196
Crosstalk of Notch with p53 and p63 in cancer growth control
Dotto, G. P. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2675 · Cited by 195
PAX3–FOXO1 fusion gene in rhabdomyosarcoma
Linardic, C. M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.035 · Cited by 176
Circadian Clock, Cancer, and Chemotherapy
Sancar, A., Lindsey-Boltz, L. A., Gaddameedhi, S., Selby, C. P., Ye, R., Chiou, Y.-Y., Kemp, M. G., Hu, J., Lee, J. H., & Ozturk, N. (2015) · Biochemistry · doi:10.1021/bi5007354 · Cited by 170
One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy
Shuvalov, O., Petukhov, A., Daks, A., Fedorova, O., Vasileva, E., & Barlev, N. A. (2017) · Oncotarget · doi:10.18632/oncotarget.15053 · Cited by 168
p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner
Molchadsky, A., Shats, I., Goldfinger, N., Pevsner‐Fischer, M., Olson, M., Rinon, A., Tzahor, E., Lozano, G., Zipori, D., Sarig, R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003707 · Cited by 165
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V., & Sarig, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq101 · Cited by 161
p53 downregulates Down syndrome‐associated DYRK1A through miR‐1246
Zhang, Y., Liao, J., Zeng, S. X., & Lu, H. (2011) · EMBO Reports · doi:10.1038/embor.2011.98 · Cited by 150
p53 and stem cells: new developments and new concerns
Zhao, T., & Xu, Y. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.12.004 · Cited by 147
Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations
Ohgami, R. S., Ma, L., Merker, J. D., Gotlib, J. R., Schrijver, I., Zehnder, J. L., & Arber, D. A. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.160 · Cited by 141
Cell death in the skin
Lippens, S., Hoste, E., Vandenabeele, P., Agostinis, P., & Declercq, W. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0324-z · Cited by 146
Ion beam radiobiology and cancer: Time to update ourselves
Fokas, E., Kraft, G., An, H., & Engenhart‐Cabillic, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.07.005 · Cited by 134
Back to basics: how natural products can provide the basis for new therapeutics
Deorukhkar, A., Krishnan, S., Sethi, G., & Aggarwal, B. B. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.11.1753 · Cited by 131
RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
Rahman, M. A., Amin, A. R. M. R., Wang, D., Koenig, L., Nannapaneni, S., Chen, Z., Wang, Z., Sica, G., Deng, X., Chen, Z., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0073 · Cited by 127
Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation
Zhou, W. J., Tian, D., He, J., Wang, Y., Zhang, L., Cui, L., Li, J., Zhang, L., Li, L., Shu, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7842 · Cited by 126
ΔNp63 Versatilely Regulates a Broad NF-κB Gene Program and Promotes Squamous Epithelial Proliferation, Migration, and Inflammation
Yang, X., Lü, H., Yan, B., Romano, R.-A., Bian, Y., Friedman, J., Duggal, P., Allen, C. T., Chuang, R. J., Ehsanian, R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3445 · Cited by 122
p53: emerging roles in stem cells, development and beyond
Jain, A. K., & Barton, M. C. (2018) · Development · doi:10.1242/dev.158360 · Cited by 130
Regulation of p53 is critical for vertebrate limb regeneration
Yun, M. H., Gates, P. B., & Brockes, J. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310519110 · Cited by 116
DNA Binding Cooperativity of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis
Schlereth, K., Beinoraviciute-Kellner, R., Zeitlinger, M. K., Bretz, A. C., Sauer, M., Charles, J. P., Vogiatzi, F., Leich, E., Samans, B., Eilers, M., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.037 · Cited by 113
Self-citation
Intermolecular Interactions of Sprouty Proteins and Their Implications in Development and Disease
Edwin, F., Anderson, K. M., Ying, C., & Patel, T. B. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055848 · Cited by 116
p53 coordinates cranial neural crest cell growth and epithelial-mesenchymal transition/delamination processes
Rinon, A., Molchadsky, A., Nathan, E., Yovel, G., Rotter, V., Sarig, R., & Tzahor, E. (2011) · Development · doi:10.1242/dev.053645 · Cited by 118
MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388)
Khurana, A., & Shafer, D. A. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s172315 · Cited by 111
Small-molecule MDM2 inhibitors in clinical trials for cancer therapy
Wang, S., & Chen, F. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114334 · Cited by 104
Evidence for a biphasic apoptotic pathway induced by melatonin in MCF‐7 breast cancer cells
Cucina, A., Proietti, S., D’Anselmi, F., Coluccia, P., Dinicola, S., Frati, L., & Bizzarri, M. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00645.x · Cited by 101
Chemotherapy‐induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway
Seitz, S., Schleithoff, E. S., Koch, A., Schuster, A., Teufel, A., Staib, F., Stremmel, W., Melino, G., Krammer, P. H., Schilling, T., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24861 · Cited by 96
Genistein Enhances the Radiosensitivity of Breast Cancer Cells via G2/M Cell Cycle Arrest and Apoptosis
Liu, X., Sun, C., Jin, X., Li, P., Ye, F., Zhao, T., Gong, L., & Li, Q. (2013) · Molecules · doi:10.3390/molecules181113200 · Cited by 93
Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing
Patil, V. S., Pal, J., & Somasundaram, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6171 · Cited by 92
In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models
Brož, D. K., & Attardi, L. D. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp331 · Cited by 92
Characterization of the p53 Cistrome – DNA Binding Cooperativity Dissects p53's Tumor Suppressor Functions
Schlereth, K., Heyl, C., Krampitz, A.-M., Mernberger, M., Finkernagel, F., Scharfe, M., Jarek, M., Leich, E., Rosenwald, A., & Stiewe, T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003726 · Cited by 87
Self-citation
Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds
Nosrati, N., Bakovic, M., & Paliyath, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102050 · Cited by 95
NFκB/p53 crosstalk—a promising new therapeutic target
Schneider, G., & Krämer, O. H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.003 · Cited by 87
Regulation of p53 family members by the ubiquitin-like SUMO system
Stehmeier, P., & Muller, S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.002 · Cited by 83
Dual roles of Drosophila p53 in cell death and cell differentiation
Fan, Y., Lee, T. V., Xu, D., Chen, Z., Lamblin, A.-F., Steller, H., & Bergmann, A. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.182 · Cited by 86
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma
Costa, P. M., Cardoso, A. L., Nóbrega, C., Pereira de Almeida, L. F., Bruce, J. N., Canoll, P., & Pedroso de Lima, M. C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds496 · Cited by 80
A gene expression profile of stem cell pluripotentiality and differentiation is conserved across diverse solid and hematopoietic cancers
Palmer, N. P., Schmid, P. R., Berger, B., & Kohane, I. S. (2012) · Genome Biology · doi:10.1186/gb-2012-13-8-r71 · Cited by 86
The Role of microRNA-21 in the Onset and Progression of Cancer
Singh, A. K., Singh, A. K., Giri, R., Kumar, D., Sharma, R., Vališ, M., Kuča, K., & Garg, N. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0096 · Cited by 81
Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells
Natarajan, U., Venkatesan, T., Radhakrishnan, V., Samuel, S., & Rathinavelu, A. (2018) · Cells · doi:10.3390/cells8010008 · Cited by 75
Cap-independent regulation of gene expression in apoptosis
Graber, T. E., & Holčı́k, M. (2007) · Molecular BioSystems · doi:10.1039/b708867a · Cited by 75
Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway
Ma, X., Choudhury, S. N., Xiang, H., Dai, Z., & Li, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt044 · Cited by 76
Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform
Slatter, T. L., Hung, N. A., Campbell, H. G., Rubio, C., Mehta, R., Renshaw, P., Williams, G., Wilson, M., Engelmann, A., Jeffs, A. R., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321851 · Cited by 76
Amphiregulin Induces the Alternative Splicing of p73 Into Its Oncogenic Isoform ΔEx2p73 in Human Hepatocellular Tumors
Castillo, J., Goñi, S., Latasa, M. U., Perugorria, M. J., Calvo, A., Muntané, J., Bioulac‐Sage, P., Balabaud, C. P., Prìeto, J., Avila, M. A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.065 · Cited by 71
p53 Regulates Neural Stem Cell Proliferation and Differentiation via BMP-Smad1 Signaling and Id1
Liu, H., Jia, D., Li, A., Chau, J. F. L., He, D. N., Ruan, X., Liu, F., Li, J., He, L., & Li, B. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0370 · Cited by 69
A FRT-flankedp53mouse to generate primary tumors with Flp recombinase
Lee, C., Moding, E. J., Huang, X., Li, Y., Woodlief, L. Z., Rodrigues, R. C., Ma, Y., & Kirsch, D. G. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.009084 · Cited by 73
Astemizole–Histamine induces Beclin-1-independent autophagy by targeting p53-dependent crosstalk between autophagy and apoptosis
Jakhar, R., Paul, S., Bhardwaj, M., & Kang, S. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.12.024 · Cited by 68
A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network
Lunardi, A., Minin, G. D., Provero, P., Ferro, M. D., Carotti, M., Sal, G. D., & Collavin, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002447107 · Cited by 66
p53’s Extended Reach: The Mutant p53 Secretome
Pavlakis, E., & Stiewe, T. (2020) · Biomolecules · doi:10.3390/biom10020307 · Cited by 66
Self-citation
Induction of Cancer Cell Death by Isoflavone: The Role of Multiple Signaling Pathways
Li, Y., Kong, D., Bao, B., Ahmad, A., & Sarkar, F. H. (2011) · Nutrients · doi:10.3390/nu3100877 · Cited by 65
AKR1B10, a Transcriptional Target of p53, Is Downregulated in Colorectal Cancers Associated with Poor Prognosis
Ohashi, T., Idogawa, M., Sasaki, Y., Suzuki, H., & Tokino, T. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0330-t · Cited by 63
Induction of genetic instability by gain-of-function p53 cancer mutants
Xu, Y. (2008) · Oncogene · doi:10.1038/sj.onc.1211023 · Cited by 63
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
Lee, J. H., & Sancar, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106284108 · Cited by 65
Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness
Tamura, M., Sasaki, Y., Koyama, R., Takeda, K., Idogawa, M., & Tokino, T. (2013) · Oncogene · doi:10.1038/onc.2013.427 · Cited by 61
Purification and Characterization of Adipose-Derived Stem Cells from Patients with Lipoaspirate Transplant
Folgiero, V., Migliano, E., TEDESCO, M., Iacovelli, S., Bon, G., Torre, M. L., Sacchi, A., Marazzi, M., Bucher, S., & Falcioni, R. (2010) · Cell Transplantation · doi:10.3727/09638910x519265 · Cited by 60
C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity
Sauer, M., Bretz, A. C., Beinoravičiūtė-Kellner, R., Beitzinger, M., Burek, M., Rosenwald, A., Harms, G. S., & Stiewe, T. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn044 · Cited by 64
Self-citation
p53 Interaction with JMJD3 Results in Its Nuclear Distribution during Mouse Neural Stem Cell Differentiation
Solá, S., Xavier, J. M., dos Santos, D. M., Aranha, M. M., Morgado, A. L., Jepsen, K., & Rodrigues, C. M. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018421 · Cited by 61
VEGFC/FLT4-induced cell-cycle arrest mediates sprouting and differentiation of venous and lymphatic endothelial cells
Jerafi-Vider, A., Bassi, I., Moshe, N., Tevet, Y., Hen, G., Splittstoesser, D., Shin, M., Lawson, N. D., & Yaniv, K. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109255 · Cited by 59
SPATA18, a Spermatogenesis-Associated Gene, Is a Novel Transcriptional Target of p53 and p63
Bornstein, C., Brosh, R., Molchadsky, A., Madar, S., Kogan-Sakin, I., Goldstein, I., Chakravarti, D., Flores, E. R., Goldfinger, N., Sarig, R., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01072-10 · Cited by 63
The tumor suppressors pRB and p53 as regulators of adipocyte differentiation and function
Hallenborg, P., Feddersen, S., Madsen, L., & Kristiansen, K. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14712590802680141 · Cited by 62
pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation
Boix, O., Martinez, M., Vidal, S., Giménez-Alejandre, M., Palenzuela, L., Lorenzo-Sanz, L., Quevedo, L., Moscoso, O., Ruiz‐Orera, J., Ximénez‐Embún, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34529-6 · Cited by 57
p53 suppresses carcinoma progression by inhibiting mTOR pathway activation
Akeno, N., Miller, A. L., Ma, X., & Wikenheiser‐Brokamp, K. A. (2014) · Oncogene · doi:10.1038/onc.2013.589 · Cited by 57
Human EHMT2/G9a activates p53 through methylation-independent mechanism
Rada, M., Васильева, Е. А., Lezina, L., Marouco, D. M., Antonov, A. V., Macip, S., Melino, G., & Barlev, N. A. (2016) · Oncogene · doi:10.1038/onc.2016.258 · Cited by 55
Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition
Zhou, X. Y., Hao, Q., Zhang, Q., Jm, L., Jw, K., Liao, P., Cao, B., & Lu, H. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.167 · Cited by 55
Thymoquinone Anticancer Discovery: Possible Mechanisms
El‐Far, A. H. (2015) · Current Drug Discovery Technologies · doi:10.2174/1570163812666150716111821 · Cited by 54
p53 orchestrates between normal differentiation and cancer
Rivlin, N., Koifman, G., & Rotter, V. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.006 · Cited by 56
The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting
Lunghi, P., Costanzo, A., Mazzera, L., Rizzoli, V., Levrero, M., & Bonati, A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1229 · Cited by 54
Atypical GATA transcription factor TRPS1 represses gene expression by recruiting CHD4/NuRD(MTA2) and suppresses cell migration and invasion by repressing TP63 expression
Wang, Y., Lin, X., Gong, X. Q., Wu, L., Zhang, J., Liu, W., Li, J., & Chen, L. (2018) · Oncogenesis · doi:10.1038/s41389-018-0108-9 · Cited by 54
Ganoderma lucidum Polysaccharides Induce Macrophage‐Like Differentiation in Human Leukemia THP‐1 Cells via Caspase and p53 Activation
Hsu, J., Huang, H., Chen, S., Wong, C., & Juan, H. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep107 · Cited by 53
Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers
Lønning, P. E., & Knappskog, S. (2013) · Oncogene · doi:10.1038/onc.2013.48 · Cited by 54
p73 poses a barrier to malignant transformation by limiting anchorage‐independent growth
Beitzinger, M., Hofmann, L., Oswald, C., Beinoravičiūtė-Kellner, R., Sauer, M., Griesmann, H., Bretz, A. C., Burek, C., Rosenwald, A., & Stiewe, T. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.13 · Cited by 52
Self-citation
Clinical Therapy Using iPSCs: Hopes and Challenges
Lu, X., & Zhao, T. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.002 · Cited by 52
Interaction of long noncoding RNA MEG3 with miRNAs: A reciprocal regulation
Moradi, M., Fallahi, H., & Rahimi, Z. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27604 · Cited by 50
Interactions of circadian clock genes with the hallmarks of cancer
Ortega-Campos, S. M., Verdugo‐Sivianes, E. M., Amiama-Roig, A., Blanco, J. R., & Carnero, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188900 · Cited by 53
Beclin‐1–p53 interaction is crucial for cell fate determination in embryonal carcinoma cells
Tripathi, R. P., Ash, D., & Shaha, C. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12386 · Cited by 49
Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression
Chen, J., Wang, F., & Chen, W. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3329-9 · Cited by 48
Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma
NUTTHASIRIKUL, N., Limpaiboon, T., Leelayuwat, C., Patrakitkomjorn, S., & Jearanaikoon, P. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1818 · Cited by 48
ASPP2 suppresses squamous cell carcinoma via RelA/p65–mediated repression of p63
Tordella, L., Koch, S., Salter, V., Pagotto, A., Doondeea, J. B., Feller, S. M., Ratnayaka, I., Zhong, S., Goldin, R. D., Lozano, G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309362110 · Cited by 48
Exploring the recent trends in perturbing the cellular signaling pathways in cancer by natural products
Rahman, M. M., Sarker, M. T., Tumpa, M. A. A., Yamin, M., Islam, T., Park, M. N., Islam, M. R., Rauf, A., Sharma, R., Cavalu, S. D., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.950109 · Cited by 50
Signaling to the p53 Tumor Suppressor through Pathways Activated by Genotoxic and Non-Genotoxic Stresses
Anderson, C. W., & Appella, E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00264-3 · Cited by 49
New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
Guo, G., & Cui, Y. R. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0053-5 · Cited by 47
Caspases and p53 modulate FOXO3A/Id1 signaling during mouse neural stem cell differentiation
Aranha, M. M., Solá, S., Low, W. C., Steer, C. J., & Rodrigues, C. M. P. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22172 · Cited by 44

Authors: Stiewe, T.
Affiliations: University of Würzburg (DE)
Corresponding author: Stiewe, Thorsten
ORCID: Stiewe, Thorsten
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2007-02-01
Volume: 7
Issue: 3
Pages: 165-167
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2072
OpenAlex: W2012024423
Cited by: 306
References: 38
Citations by year: 2026: 3 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 12 · 2021: 12 · 2020: 11 · 2019: 7 · 2018: 16 · 2017: 10 · 2016: 8 · 2015: 18 · 2014: 27 · 2013: 31 · 2012: 21
FWCI: 2.98
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53 family, p63, p73, tumour suppressor, cell differentiation, carcinogenesis, embryonic development, cell cycle arrest, apoptosis, transcription factors
MeSH terms: Animals, Cell Differentiation, Cell Transformation, Neoplastic, Humans, Genes, p53

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The p53 family in differentiation and tumorigenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks